MedTrace Logo

Freestyle Libre Flash Glucose Monitoring System

NCT03607448 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2018-11-29

No results posted yet for this study

Summary

The purpose of this study is to characterize the Freestyle Libre Flash Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.

Conditions

Interventions

DEVICE

Freestyle Libre Flash Glucose Monitoring System

Subjects will wear the Abbott Sensor based FreeStyle Libre Flash Glucose Monitoring System and will receive no treatment except for safety purposes

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Shridhara Karinka, PhD · Abbott Diabetes Care

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-23
Primary Completion
2018-11-21
Completion
2018-11-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03607448 on ClinicalTrials.gov